Guidance, NICE advice and quality standards in development | Guidance

Showing 71 to 80 of 404

Sort by

Guidance, NICE advice and quality standards in development
Title	Type	Expected publication date
Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (review of HST12) [ID6145]	Highly specialised technology	TBC
Chronic heart failure in adults: diagnosis and management - Pharmacological treatment of chronic heart failure	NICE guideline	TBC
Ciltacabtagene autoleucel for treating relapsed and lenalidomide-refractory multiple myeloma after 1 to 3 therapies [ID4012]	Technology appraisal guidance	TBC
Cimavax for treating wild-type EGFR-positive non-small-cell lung cancer [1259]	Technology appraisal guidance	TBC
Cladribine for treating relapsing multiple sclerosis [ID6263]	Technology appraisal guidance	5 February 2025
Cobolimab with dostarlimab and docetaxel for treating advanced non-small-cell lung cancer after anti-PD-L1 treatment and chemotherapy [ID6398]	Technology appraisal guidance	TBC
COLOFIT algorithm to guide colorectal cancer pathway referral in primary care: early value assessment	Health technology evaluation	TBC
Colon cancer (adjuvant) - irinotecan [ID379]	Technology appraisal guidance	TBC
Compression products for treating venous leg ulcers: late stage assessment	Health technology evaluation	27 August 2025
Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis	Interventional procedures guidance	5 February 2025